Endocrinology, Vol 129, 2187-2193, Copyright © 1991 by Endocrine Society

ARTICLES

Coexpression of functionally active receptors for thyrotropin and platelet-derived growth factor in human thyroid carcinoma cells

NE Heldin, D Cvejic, S Smeds and B Westermark
Department of Pathology, University Hospital, Uppsala, Sweden.

In the present study we show the simultaneous expression of functionally active receptors for TSH and platelet-derived growth factor (PDGF) in a newly established human anaplastic thyroid carcinoma cell line, HTh 74. In Northern blot analysis of RNA extracted from HTh 74 cells a low expression of both TSH and PDGF receptor messenger RNA was found. These observations in conjunction with the fact that the cells contain cytokeratin clearly demonstrate that the cells are bona fide epithelial thyroid cells. Stimulation of HTh 74 cells with TSH led to a concentration-dependent increase in cAMP formation, showing a functional activity of the TSH receptors. Northern blot analysis, immunoprecipitation, immunofluorescence staining, and binding experiments showed the presence of both alpha- and beta-type PDGF receptors in the HTh 74 cells. The functional activity of the PDGF receptors was demonstrated by ligand-induced internalization of the receptors and PDGF-induced growth of the HTh 74 cells. The significance of the expression of PDGF receptors on thyroid epithelial cells is not clear. However, it might reflect the gain of a new growth stimulatory pathway participating in the transformation of the epithelial thyroid cells. Alternatively, the PDGF receptors may be remnants from an immature progenitor cell from which the undifferentiated carcinoma has evolved.

This article has been cited by other articles:

				G. Salvatore, T. C. Nappi, P. Salerno, Y. Jiang, C. Garbi, C. Ugolini, P. Miccoli, F. Basolo, M. D. Castellone, A. M. Cirafici, et al. A Cell Proliferation and Chromosomal Instability Signature in Anaplastic Thyroid Carcinoma Cancer Res., November 1, 2007; 67(21): 10148 - 10158. [Abstract] [Full Text] [PDF]

				D. Calebiro, T. de Filippis, S. Lucchi, F. Martinez, P. Porazzi, R. Trivellato, M. Locati, P. Beck-Peccoz, and L. Persani Selective Modulation of Protein Kinase A I and II Reveals Distinct Roles in Thyroid Cell Gene Expression and Growth Mol. Endocrinol., December 1, 2006; 20(12): 3196 - 3211. [Abstract] [Full Text] [PDF]

				J. M. Dziba and K. B. Ain Imatinib Mesylate (Gleevec; STI571) Monotherapy Is Ineffective in Suppressing Human Anaplastic Thyroid Carcinoma Cell Growth in Vitro J. Clin. Endocrinol. Metab., May 1, 2004; 89(5): 2127 - 2135. [Abstract] [Full Text] [PDF]

				M. Eszlinger, K. Krohn, and R. Paschke Complementary DNA Expression Array Analysis Suggests a Lower Expression of Signal Transduction Proteins and Receptors in Cold and Hot Thyroid Nodules J. Clin. Endocrinol. Metab., October 1, 2001; 86(10): 4834 - 4842. [Abstract] [Full Text] [PDF]

				J. Kurebayashi, K. Tanaka, T. Otsuki, T. Moriya, H. Kunisue, M. Uno, and H. Sonoo All-Trans-Retinoic Acid Modulates Expression Levels of Thyroglobulin and Cytokines in a New Human Poorly Differentiated Papillary Thyroid Carcinoma Cell Line, KTC-1 J. Clin. Endocrinol. Metab., August 1, 2000; 85(8): 2889 - 2896. [Abstract] [Full Text]

				A. Brunetti, E. Chiefari, S. Filetti, and D. Russo The 3',5'-Cyclic Adenosine Monophosphate Response Element Binding Protein (CREB) Is Functionally Reduced in Human Toxic Thyroid Adenomas Endocrinology, February 1, 2000; 141(2): 722 - 730. [Abstract] [Full Text] [PDF]

				M. Derwahl, M. Broecker, and Z. Kraiem Thyrotropin May Not Be the Dominant Growth Factor in Benign and Malignant Thyroid Tumors J. Clin. Endocrinol. Metab., March 1, 1999; 84(3): 829 - 834. [Full Text]

				M. Broecker, G. W. Mayr, and M. Derwahl Suppression of Thyrotropin Receptor-G Protein-Phospholipase C Coupling by Activation of Protein Kinase C in Thyroid Carcinoma Cells Endocrinology, September 1, 1997; 138(9): 3787 - 3796. [Abstract] [Full Text] [PDF]

				K. Ohta, X.-P. Pang, L. Berg, and J. M. Hershman Growth Inhibition of New Human Thyroid Carcinoma Cell Lines by Activation of Adenylate Cyclase through the {beta}-Adrenergic Receptor J. Clin. Endocrinol. Metab., August 1, 1997; 82(8): 2633 - 2638. [Abstract] [Full Text] [PDF]